Bioneer Develops Ebola MDx Kit in Partnership with Nigerian Biotech Agency | GenomeWeb

NEW YORK (GenomeWeb) — South Korean molecular diagnostics firm Bioneer announced on Wednesday the availability of a molecular test kit for the Ebola virus that it has developed in collaboration with the Nigerian National Biotechnology Development Agency (NABDA).

Specifically, the company's AccuPower EBOV real-time RT-PCR kit is optimized for detection of the Zaire subtype of the Ebola virus associated with recent outbreaks in Africa. Bioneer has worked with NABDA since April to develop means to rapidly detect this subtype.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.